NeuronX is an AI platform that analyzes medical data to support diagnosis, treatment planning, and predictive healthcare insights.
NeuronX has raised $1.0M in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2025.
NeuronX's investors include Startup Wise Guys, Ecco Capital, Eureka Partners, AU21 Capital, Obelisk Capital.
NeuronX is headquartered in San Francisco, United States.
NeuronX is an AI platform that analyzes medical data to support diagnosis, treatment planning, and predictive healthcare insights.
NeuronX is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuronX — Funding & Investors." VCBacked, March 17, 2025, https://www.vcbacked.co/company/neuronx. Accessed September 7, 2026.
VCBacked. (2025). NeuronX — Funding & Investors. Retrieved September 7, 2026, from https://www.vcbacked.co/company/neuronx
{{cite web |title=NeuronX — Funding & Investors |url=https://www.vcbacked.co/company/neuronx |website=VCBacked |access-date=September 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated